Sequent Scientific Ltd.

NSE: SEQUENT | BSE: 512529 | ISIN: INE807F01027 |Industry: Pharmaceuticals
|Expensive Star
148.10 -1.40 (-0.94%)
NSE Oct 19, 2020 15:31 PM
Volume: 609.9K

Sequent Scientific Ltd.    
01 Aug 2019
Nirmal Bang Institutional
Sequent Scientific or SSLs 1QFY20 revenue at Rs2,780mn was below our estimate by 3.6%. On a QoQ basis, the performance was flattish across segments, except Emerging Markets formulations business, which grew by 14% QoQ. API sales (Rs900mn) were up 50% YoY but declined by 10% QoQ. The company is expecting API sales to exceed Rs 4000mn in FY20 and hence the run-rate in coming quarters should strengthen. To ensure enough capacities for the near to medium term the...
Sequent Scientific L.. has an average target of 146.33 from 3 brokers.
More from Sequent Scientific Ltd.